Unlike most biotech IPOs, 10X Genomics already has nine-figure revenue, and CEO Serge Saxonov says thee's more to come.

source https://finance.yahoo.com/m/6edfa7ba-9198-3f0d-b2fb-82cfa6323e48/after-record-ipo%2C-east-bay.html?.tsrc=rss